220 related articles for article (PubMed ID: 28750683)
21. Epigenetic mechanisms in the biology of prostate cancer.
Schulz WA; Hoffmann MJ
Semin Cancer Biol; 2009 Jun; 19(3):172-80. PubMed ID: 19429481
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
23. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1.
Feng YX; Jin DX; Sokol ES; Reinhardt F; Miller DH; Gupta PB
Nat Commun; 2017 Oct; 8(1):1079. PubMed ID: 29057869
[TBL] [Abstract][Full Text] [Related]
24. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
[TBL] [Abstract][Full Text] [Related]
25. Regulatory roles of Oct proteins in the mammary gland.
Qian X; Zhao FQ
Biochim Biophys Acta; 2016 Jun; 1859(6):812-9. PubMed ID: 27044595
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic modulators as therapeutic targets in prostate cancer.
Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
[TBL] [Abstract][Full Text] [Related]
27. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
28. The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer.
Bicker A; Brahmer AM; Meller S; Kristiansen G; Gorr TA; Hankeln T
PLoS One; 2015; 10(11):e0142662. PubMed ID: 26559958
[TBL] [Abstract][Full Text] [Related]
29. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
30. In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
Perry AS; Loftus B; Moroose R; Lynch TH; Hollywood D; Watson RW; Woodson K; Lawler M
Br J Cancer; 2007 May; 96(10):1587-94. PubMed ID: 17453001
[TBL] [Abstract][Full Text] [Related]
31. Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells.
Bonacini M; Coletta M; Ramazzina I; Naponelli V; Modernelli A; Davalli P; Bettuzzi S; Rizzi F
Biochim Biophys Acta; 2015 Jan; 1849(1):44-54. PubMed ID: 25464035
[TBL] [Abstract][Full Text] [Related]
32. Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer.
Wang S; Clarke PAG; Davis R; Mumuni S; Kwabi-Addo B
Cytokine; 2016 Oct; 86():110-118. PubMed ID: 27500645
[TBL] [Abstract][Full Text] [Related]
33. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors.
Mancini DN; Singh SM; Archer TK; Rodenhiser DI
Oncogene; 1999 Jul; 18(28):4108-19. PubMed ID: 10435592
[TBL] [Abstract][Full Text] [Related]
34. Dynamic changes in DNA methylation during thermal control establishment affect CREB binding to the brain-derived neurotrophic factor promoter.
Yossifoff M; Kisliouk T; Meiri N
Eur J Neurosci; 2008 Dec; 28(11):2267-77. PubMed ID: 19046370
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation profiling in human Huntington's disease brain.
De Souza RA; Islam SA; McEwen LM; Mathelier A; Hill A; Mah SM; Wasserman WW; Kobor MS; Leavitt BR
Hum Mol Genet; 2016 May; 25(10):2013-2030. PubMed ID: 26953320
[TBL] [Abstract][Full Text] [Related]
36. Comparative DNA methylation and gene expression analysis identifies novel genes for structural congenital heart diseases.
Grunert M; Dorn C; Cui H; Dunkel I; Schulz K; Schoenhals S; Sun W; Berger F; Chen W; Sperling SR
Cardiovasc Res; 2016 Oct; 112(1):464-77. PubMed ID: 27496870
[TBL] [Abstract][Full Text] [Related]
37. Identification of key regulators in prostate cancer from gene expression datasets of patients.
Mangangcha IR; Malik MZ; Küçük Ö; Ali S; Singh RKB
Sci Rep; 2019 Nov; 9(1):16420. PubMed ID: 31712650
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
[TBL] [Abstract][Full Text] [Related]
39. Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer development.
Chen Y; Widschwendter M; Teschendorff AE
Genome Biol; 2017 Dec; 18(1):236. PubMed ID: 29262847
[TBL] [Abstract][Full Text] [Related]
40. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
Tang H; Goldberg E
J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]